Tumor-intrinsic PTPN12 suppresses anti-tumor immunity in colorectal cancer by restraining a dual epigenetic and cytoskeletal dsRNA sensing program
Abnormal endogenous dsRNA generation and/or sensing and the resulting interferon responses contribute to immunotherapy resistance in microsatellitestable colorectal cancer (MSS-CRC).